| Revenue | 101,478.26a | 98,322.55a |
| Cost of revenue | -81,008.68a | -79,294.23a |
| Gross profit | 20,469.58a | 19,028.31a |
| Selling expenses | -2,927.84a | -2,623.76a |
| Administrative expenses | -3,404.85a | -3,325.56a |
| Research and development expenses | -3,858.99a | -3,631.91a |
| Expected credit impairment (loss) gain | 34.74a | -38.07a |
| Total operating expenses | -10,156.94a | -9,619.31a |
| Operating income | 10,312.63a | 9,409a |
| Other income | 2,183a | 1,285.58a |
| Other gains and losses | 938.91a | 694.52a |
| Finance costs | -133.43a | -125.91a |
| Share of profit (loss) of investments accounted for using the equity method | -5.29a | 9.73a |
| Total non-operating income and expenses | 2,983.18a | 1,863.91a |
| Profit before tax | 13,295.82a | 11,272.92a |
| Income tax expense | -2,591.93a | -2,273.2a |
| Net income | 10,703.89a | 8,999.71a |